Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection.
about
Phenotypes, Risk Factors, and Mechanisms of Adult-Onset Asthmabeta2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cellsSeroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease.Age-of-asthma onset as a determinant of different asthma phenotypes in adults: a systematic review and meta-analysis of the literature.Chlamydia pneumoniae infection enhances cellular proliferation and reduces steroid responsiveness of human peripheral blood mononuclear cells via a tumor necrosis factor-alpha-dependent pathway.Asthma microbiome studies and the potential for new therapeutic strategiesNo direct association between asthma and the microbiome based on currently available techniques.Mechanisms of severe asthma.Chlamydia pneumoniae infections in asthma: clinical implications.Changes in immune function in asthma in the elderlyThe emerging relationship between the airway microbiota and chronic respiratory disease: clinical implicationsSevere asthma in adults.Severe asthma in children.Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?Corticosteroid responsiveness and clinical characteristics in childhood difficult asthmaAirway closure on imaging relates to airway hyperresponsiveness and peripheral airway disease in asthmaUnusual asthma syndromes and their managementCXC chemokine superfamily induced by Interferon-γ in asthma: a cross-sectional observational study.The role of anti-infectives in the treatment of refractory asthma.Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases.Chlamydia pneumoniae activates epithelial cell proliferation via NF-kappaB and the glucocorticoid receptor.Detection and differentiation of chlamydiae by fluorescence in situ hybridization.Lung damage and airway remodelling in severe asthma.Current treatment of severe asthma.Asthma in the elderly and late-onset adult asthma.Atypical bacteria and macrolides in asthmaInflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO.Is Chlamydia pneumoniae important in asthma? The first controlled trial of therapy leaves the question unanswered.Mannose-binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults.Older adults with asthma: does age of asthma onset make a difference?Three phenotypes of adult-onset asthma.The microbiome of the human lower airways: a next generation sequencing perspective.Airway inflammation in obese and nonobese patients with difficult-to-treat asthma.Asthma and autoimmunity: a complex but intriguing relation.
P2860
Q26779940-2779B23D-5495-4BBB-9448-BDE40E9F486BQ33578314-61326CA7-1E94-460C-8989-D9A325B275A1Q33599500-E22FF685-1B5D-45CD-A73C-824FD10EB69FQ34458002-44734EB7-61D8-4E81-98BD-5DB784645F2AQ34481798-E3D15570-8E55-4C71-83A9-2E822A68F384Q34741123-D4649B58-B73C-4AFF-924F-6E3A89738654Q35514135-1FF79847-EB19-4894-BC41-CAA31444117CQ35600558-FB6D7789-D730-4D37-BAFA-1C55F0F3833FQ35627745-BE1B06C4-46BF-4846-85E6-3D0C3FD605BDQ35986169-A55ACE31-7A02-42ED-BF72-30C7B5F47BC8Q35987288-79FD5622-9DED-487D-A130-A37F8055DEA9Q36105312-E58912B4-AC64-4895-BC5C-14E22B3D32DFQ36108246-DA8CC0AB-E8D3-402B-8DA4-B572ED9D3946Q36165742-29DBBF6E-0589-4011-B4CF-601FA9A6BBA9Q36316780-2C9DC8CA-2EBC-4C40-98D6-5FE7FB5D0E95Q36320869-7D177FE0-CE07-4450-993A-034CFB239E3CQ36443760-BFA02D7A-194A-4D42-BC5C-E541D0335217Q37481279-66FF0891-0F2D-45AE-89D1-3F72C077E051Q37860762-541F1E3F-56C1-4D50-B660-83266141D400Q37864015-0F3A7D10-D90B-4B9A-9B0F-3BFA660DC0FAQ37868580-D583EBA2-5955-4F2B-B7BF-38B4F3FAA2EEQ37871518-29861C82-A8BF-4D2D-AA03-99C41C082907Q37970841-F9C5E462-2222-4C36-A896-6ACA3D16FD62Q37976485-DD4FF060-432C-48A0-AA1A-9F96804C2F71Q39444012-B21FC208-4431-4C6B-B6A0-B9DBB0F8A21AQ40518030-BBECC1E0-82A4-4362-8E89-CBC5E6F81CD6Q43297954-6BBF5C42-9152-4CA9-8BE0-B00B001A63B8Q43424830-1BCA18BE-F7D5-4583-963B-DE392F738539Q44086958-04BB11D7-4143-4356-8815-C5342B9A91CCQ45740071-ED24DE70-1CED-4613-9C23-D7885F2672E4Q45967759-075E82D8-2D10-4564-973E-0FE0B8E99168Q46093186-9F7BEC00-E797-4D89-9C56-C51F2373D9C9Q48438171-8552B4F2-FFEC-493D-AB55-2FC9EDAA6652Q51676365-F3A8EBC7-D8F8-4E08-9CA8-E3E120B32899
P2860
Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2001
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Persistent airflow limitation ...... hlamydia pneumoniae infection.
@en
Persistent airflow limitation ...... hlamydia pneumoniae infection.
@nl
type
label
Persistent airflow limitation ...... hlamydia pneumoniae infection.
@en
Persistent airflow limitation ...... hlamydia pneumoniae infection.
@nl
prefLabel
Persistent airflow limitation ...... hlamydia pneumoniae infection.
@en
Persistent airflow limitation ...... hlamydia pneumoniae infection.
@nl
P2093
P356
P1476
Persistent airflow limitation ...... hlamydia pneumoniae infection.
@en
P2093
Zwinderman AH
ten Brinke A
van Dissel JT
P304
P356
10.1067/MAI.2001.113047
P407
P577
2001-03-01T00:00:00Z